Join the graduate scheme as a trainee recruitment consultant at an established and highly - regarded Life Sciences recruitment firm with an amazing client base, ranging from
big pharmaceutical firms (like GSK, Pfizer, AstraZeneca), small - mid sized bio farmers...
Most large R&D - driven companies, including
the big pharmaceutical firms, have offered this option for years.
Not exact matches
Two private equity
firms will pay $ 1.23 billion for Australian drug developer and marketer iNova
Pharmaceuticals, in the latest sign that private equity buyers are cashed up and willing to write
big cheques.
The list of top donors to housekeeping accounts is dominated by special interests that are highly regulated and / or subsidized by state government: real estate
firms, health - care and
pharmaceutical interests, labor unions, telecom companies, the beverage industry,
big tobacco and gambling interests.
«
Big pharma has been fairly resilient, with
pharmaceutical firms continuing to hire for drug development.
The
big employers of nontraditional chemists include all the science companies — chemical companies, biotech companies,
pharmaceutical companies — but also law
firms, companies involved in public policy, and companies involved in manufacturing or information technology.
That's less than biotechnology (at $ 365 billion) and
pharmaceuticals (at $ 1094 billion), but it's a
big industry — according to a report by the consulting
firm Frost & Sullivan, it's projected to grow over the next 3 to 5 years at an annual rate of 9 %, a growth rate comparable to
big pharma.
Today, scientists targeting industry can choose from a variety of specialized training courses, which can make a
big difference in their «marketability» for jobs at biotechnology,
pharmaceutical, medical device, and other
firms offering scientific employment opportunities.
Though many doubted that large institutions like law
firms are capable of change, one participant, Professor John Coates (formerly of Wachtell, which he left because he felt that the
firm's structure and clients stymied true innovation) offered the idea that law
firms might follow the example of
big pharmaceutical companies that have created innovative research subsidiaries, often teaming with startup companies.
Two of New York's
biggest firms have secured mandates on Teva
Pharmaceutical's $ 40.5 bn (# 26bn) purchase of fellow
pharmaceutical company Allergan's Generics business.
In addition to his work defending
pharmaceutical clients, Brett has spent considerable time defending
Big Four accounting
firms in civil suits and representing both
Big Four
firms and their partners in regulatory investigations and administrative proceedings.
Sindhu Daniel manages the
firm's
Pharmaceutical Litigation Group and has a passion for representing people harmed by
big pharmaceutical companies which have marketed their products as safe when they are not or have otherwise misrepresented the efficacy and toxicity of their medical commodities.
Mr. Budd, a shareholder of Baron & Budd since 1985 and president and managing shareholder since 2002, has expanded the
firm from its cornerstone asbestos practice to a national
firm capable of tackling the
biggest defendants in areas as diverse as
pharmaceutical and medical device injury, water contamination, BP Gulf oil spill, financial fraud and various other areas of practice.
Summary of Qualifications * President and owner Coastal Drug Institutional Pharmacy in Maryland * 10 yrs as Pharmacist in Charge for Long Term Care Pharmacy * Senior Management Consultant for
Big 5 consulting
firm * Six Sigma Black Belt * Associate Director of Project Management for biopharmaceutical company * Director of Clinical Benchmarking for mid-tier consulting
firm * Project Manager for top 10
pharmaceutical company *...
Summary of Experience: Decades of experience in information technology, holding staff, supervisory and management positions in major divisions of Fortune 100 companies and a
Big Six professional services
firm, involved with the following industries: * Consumer Products * Financial Services (banking, brokerage, * Retail insurance) *
Pharmaceuticals * Telecommunications * Automotive * Entertainment * Transportation * Publishi...